BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
342 hedge funds and large institutions have $5.85B invested in Blueprint Medicines in 2024 Q4 according to their latest regulatory filings, with 60 funds opening new positions, 147 increasing their positions, 98 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
342
Holders Change
+26
Holders Change %
+8.23%
% of All Funds
4.55%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.11%
New
60
Increased
147
Reduced
98
Closed
28
Calls
$148M
Puts
$131M
Net Calls
+$17.5M
Net Calls Change
-$76.6M
Top Buyers
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$103M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$49.9M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$44.8M |
| 4 |
Jennison Associates
New York
|
+$31.4M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$28.6M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$198M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$73.5M |
| 3 |
Man Group
London,
United Kingdom
|
-$36.2M |
| 4 |
State Street
Boston,
Massachusetts
|
-$23.2M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$21.9M |
